U.S. biotechs could face stiffer competition.
Katherine Davis is a Biotech Deals Reporter at Axios. She specializes in covering biotech deals and has a diverse range of interests that include consumer packaged goods, education, and various aspects of sports, from individual to team dynamics. Katherine's work has been featured in notable publications such as Ad Age, BioSpace, and Modern Healthcare, among others.